Allegheny Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $890K | Hold |
2,000
| – | – | 0.2% | 100 |
|
|
2025
Q1 | $970K | Sell |
2,000
-19
| -0.9% | -$9.21K | 0.25% | 77 |
|
|
2024
Q4 | $813K | Sell |
2,019
-21
| -1% | -$8.46K | 0.21% | 90 |
|
|
2024
Q3 | $949K | Buy |
2,040
+19
| +0.9% | +$8.84K | 0.23% | 80 |
|
|
2024
Q2 | $947K | Sell |
2,021
-240
| -11% | -$112K | 0.27% | 70 |
|
|
2024
Q1 | $945K | Sell |
2,261
-66
| -3% | -$27.6K | 0.29% | 66 |
|
|
2023
Q4 | $947K | Buy |
2,327
+21
| +0.9% | +$8.55K | 0.3% | 62 |
|
|
2023
Q3 | $802K | Buy |
2,306
+306
| +15% | +$106K | 0.3% | 62 |
|
|
2023
Q2 | $704K | Hold |
2,000
| – | – | 0.33% | 56 |
|
|
2023
Q1 | $630K | Hold |
2,000
| – | – | 0.25% | 78 |
|
|
2022
Q4 | $578K | Hold |
2,000
| – | – | 0.24% | 85 |
|
|
2022
Q3 | $579K | Hold |
2,000
| – | – | 0.27% | 72 |
|
|
2022
Q2 | $564K | Hold |
2,000
| – | – | 0.26% | 75 |
|
|
2022
Q1 | $522K | Hold |
2,000
| – | – | 0.22% | 78 |
|
|
2021
Q4 | $439K | Buy |
+2,000
| New | +$439K | 0.18% | 85 |
|